Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

T. Bivona · SciRah

Researcher profile · Semantic Scholar

T. Bivona

Share profile

T. Bivona — researcher profile on SciRah

h-index: 66
Works: 293
Citations: 20K

Most-cited papers

Liquid Biopsy for Advanced Non-Small Cell Lung Cancer: A Consensus Statement from The International Association for the Study of Lung Cancer (IASLC).
C. Rolfo, P. Mack, G. Scagliotti, C. Aggarwal +24 more
2021Journal of Thoracic Oncology435 citations Open access
Semantic Scholar
Lineage Tracing Reveals the Phylodynamics, Plasticity and Paths of Tumor Evolution
Dian Yang, Matthew G. Jones, S. Naranjo, W. Rideout +19 more
2022Cell286 citations Open access
Semantic Scholar
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
F. Skoulidis, Haniel A. Araujo, Minh Truong Do, Yu Qian +127 more
2024Nature197 citations Open access
Semantic Scholar
Single-cell lineages reveal the rates, routes, and drivers of metastasis in cancer xenografts
Jeffrey J. Quinn, Matthew G. Jones, R. Okimoto, Shigeki Nanjo +4 more
2021Science138 citations Open access
Semantic Scholar
Acquired resistance in cancer: towards targeted therapeutic strategies
A. Soragni, Erik S. Knudsen, Thomas N. O'Connor, C. Tognon +19 more
2025Nature Reviews. Cancer133 citations
Semantic Scholar
Kinase-mediated RAS signaling via membraneless cytoplasmic protein granules
Asmin Tulpule, Juan Guan, Dana S. Neel, Hannah R. Allegakoen +16 more
2021Cell119 citations Open access
Semantic Scholar
Allosteric SHP2 inhibitors in cancer: Targeting the intersection of RAS, resistance, and the immune microenvironment.
D. Kerr, Franziska Haderk, T. Bivona
2021Current Opinion in Chemical Biology106 citations
Semantic Scholar
AXL and error-prone DNA replication confer drug resistance and offer strategies to treat EGFR-mutant lung cancer
Ashish Noronha, N. Nataraj, J. Lee, Binyamin Zhitomirsky +35 more
2022Cancer Discovery101 citations Open access
Semantic Scholar
PERCEPTION accurately predicts patient response and resistance to treatment using single-cell transcriptomics of their tumors
Sanju Sinha, R. Vegesna, S. Mukherjee, Ashwin V. Kammula +16 more
2024Nature Cancer98 citations Open access
Semantic Scholar
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance
D. Caswell, Philippe Gui, M. Mayekar, Emily K Law +81 more
2023Nature Genetics81 citations Open access
Semantic Scholar
Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer
Franziska Haderk, Yu-Ting Chou, Lauren Cech, C. Fernández-Méndez +31 more
2024Nature Communications77 citations Open access
Semantic Scholar
Evolution of metastasis: new tools and insights.
Philippe Gui, T. Bivona
2021Trends in Cancer74 citations Open access
Semantic Scholar
Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: A Phase II Multicenter Study
Collin M. Blakely, A. Urisman, M. Gubens, C. Mulvey +20 more
2024Journal of Clinical Oncology66 citations Open access
Semantic Scholar
Understanding Drug Sensitivity and Tackling Resistance in Cancer
J. Tyner, Franziska Haderk, A. Kumaraswamy, L. Baughn +11 more
2022Cancer Research58 citations Open access
Semantic Scholar
Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling
S. Hobor, Maise Al Bakir, C. Hiley, M. Skrzypski +291 more
2024Nature Communications49 citations Open access
Semantic Scholar
Small-molecule targeted therapies induce dependence on DNA double-strand break repair in residual tumor cells
Moiez Ali, Min Lu, H. Ang, R. Soderquist +13 more
2022Science Translational Medicine42 citations Open access
Semantic Scholar
Long Non-Coding RNAs as Emerging Targets in Lung Cancer
Jovanka Gencel-Augusto, Wei Wu, T. Bivona
2023Cancers31 citations Open access
Semantic Scholar
Myeloid-mesenchymal crosstalk drives ARG1-dependent profibrotic metabolism via ornithine in lung fibrosis
Preeti Yadav, Javier Gómez Ortega, Prerna Dabral, W. Tamaki +31 more
2025Journal of Clinical Investigation26 citations Open access
Semantic Scholar
DDX56 modulates post-transcriptional Wnt signaling through miRNAs and is associated with early recurrence in squamous cell lung carcinoma
Qing-qing Wu, Xiao-Yang Luo, M. Terp, Qingrun Li +8 more
2021Molecular Cancer25 citations Open access
Semantic Scholar
A focal adhesion kinase-YAP signaling axis drives drug tolerant persister cells and residual disease in lung cancer
Franziska Haderk, C. Fernández-Méndez, Lauren Cech, Johnny Yu +29 more
2021bioRxiv25 citations Open access
Semantic Scholar
Oncogenic EML4-ALK assemblies suppress growth factor perception and modulate drug tolerance
D. Gonzalez-Martinez, Lee Roth, T. Mumford, Juan Guan +7 more
2024Nature Communications22 citations Open access
Semantic Scholar
Phase II trial of neoadjuvant osimertinib for surgically resectable EGFR-mutated non-small cell lung cancer.
J. Aredo, A. Urisman, M. Gubens, Claire K Mulvey +16 more
2023Journal of Clinical Oncology21 citations
Semantic Scholar
Targeting AXL in NSCLC
Aubhishek Zaman, T. Bivona
2021Lung Cancer21 citations Open access
Semantic Scholar
Inhibition of SHP2 as an approach to block RAS-driven cancers.
Yu-Ting Chou, T. Bivona
2022Advances in Cancer Research20 citations
Semantic Scholar
Temporal photoproximity labeling of ligand-activated EGFR neighborhoods using MultiMap
Zhi Lin, Wayne Ngo, Yu-Ting Chou, Harry Wu +5 more
2025Nature Chemical Biology18 citations Open access
Semantic Scholar
Quantification of cerebrospinal fluid tumor DNA in lung cancer patients with suspected leptomeningeal carcinomatosis
T. Azad, Shigeki Nanjo, Michael C. Jin, J. Chabon +23 more
2024npj Precision Oncology18 citations Open access
Semantic Scholar
Digital multiplexed analysis of circular RNAs in FFPE and fresh non‐small cell lung cancer specimens
C. Pedraz-Valdunciel, S. Giannoukakos, N. Potie, A. Giménez-Capitán +14 more
2022Molecular Oncology17 citations Open access
Semantic Scholar
Targeting WEE1 to Overcome ARID1A Mutation-Driven Osimertinib Resistance in EGFR-Mutant Lung Cancer
Koji Fukuda, Shigeki Nanjo, S. Takeuchi, T. Chakrabarti +12 more
2025Journal of Thoracic Oncology13 citations Open access
Semantic Scholar
Lineage Recording Reveals the Phylodynamics, Plasticity and Paths of Tumor Evolution
Dian Yang, Matthew G. Jones, S. Naranjo, W. Rideout +19 more
2021bioRxiv12 citations Open access
Semantic Scholar
Exocyst protein subnetworks integrate Hippo and mTOR signaling to promote virus detection and cancer
Aubhishek Zaman, Xiaofeng Wu, Andrew Lemoff, Sivaramakrishna Yadavalli +8 more
2021Cell Reports12 citations Open access
Semantic Scholar
Remodeling of the tumor/tumor microenvironment ecosystem during KRAS G12C inhibitor clinical resistance in lung cancer
T. Manabe, T. Bivona
2022Journal of Clinical Investigation11 citations Open access
Semantic Scholar
Primary and metastatic tumors exhibit systems-level differences in dependence on mitochondrial respiratory function
Neal K. Bennett, Hiroki J. Nakaoka, Danny Laurent, R. Okimoto +7 more
2022PLoS Biology10 citations Open access
Semantic Scholar
3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib
I. Meraz, M. Majidi, B. Fang, F. Meng +17 more
2021bioRxiv10 citations Open access
Semantic Scholar
P26.02 A Phase II Trial of Neoadjuvant Osimertinib for Surgically Resectable EGFR-Mutant Non-Small Cell Lung Cancer: Updated Results
C. Blakely, A. Urisman, D. Kerr, Wei Wu +13 more
2021Journal of Thoracic Oncology8 citations Open access
Semantic Scholar
Stepwise evolution of therapy resistance in AML.
Philippe Gui, T. Bivona
2021Cancer Cell7 citations Open access
Semantic Scholar
Phase-Separated Biomolecular Condensation in Cancer: New Horizons and Next Frontiers.
T. Bivona
2024Cancer Discovery6 citations Open access
Semantic Scholar
A phase I/Ib study of the aurora kinase A inhibitor alisertib in combination with osimertinib in advanced osimertinib-resistant EGFR-mutated lung cancer.
T. Chakrabarti, G. Allen, M. Gubens, C. Mulvey +6 more
2024Journal of Clinical Oncology6 citations
Semantic Scholar
GATOR2-dependent mTORC1 activity is a therapeutic vulnerability in FOXO1 fusion–positive rhabdomyosarcoma
Jacqueline Morales, D. Allegakoen, J. A. García, Kristen Kwong +8 more
2022JCI Insight6 citations Open access
Semantic Scholar
Pan-RAF inhibitor exarafenib targets BRAF class II/III NSCLC and reveals ARAF-KSR1 resistance and combination strategies
Tadashi Manabe, Hannah C Bergo, Qingtian Li, Tim S Wang +20 more
2026Nature Communications5 citations Open access
Semantic Scholar
Targeting Minimal Residual Disease
Yu-Ting Chou, Paul Allegakoen, T. Bivona
2024Annual Review of Cancer Biology5 citations Open access
Semantic Scholar
FET fusion oncoproteins disrupt physiologic DNA repair networks and induce ATR synthetic lethality in cancer
Shruti Menon, Marcus R. Breese, Y. Lin, Hannah R. Allegakoen +7 more
2023Research Square5 citations Open access
Semantic Scholar
Phase 1 Study of Ceritinib Combined With Trametinib in Patients With Advanced ALK- or ROS1-Positive NSCLC
M. S. Lara, M. Gubens, Bianca Bacaltos, Lea Daran +6 more
2022JTO Clinical and Research Reports5 citations Open access
Semantic Scholar
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids.
Dora Barbosa Rabago, C. Blakely, Franziska Haderk, T. Bivona
2021Journal of Visualized Experiments5 citations Open access
Semantic Scholar
Phase I Clinical Trial Evaluating Safety, Tolerability, and Early Activity of Exarafenib (KIN-2787), a Highly Selective Pan-RAF Inhibitor, in BRAF -Altered Solid Tumors or NRAS -Mutant Melanoma
V. Gambardella, M. McKean, Richard Kim, Shumei Kato +20 more
2026JCO Oncology Advances4 citations Open access
Semantic Scholar
Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
F. Skoulidis, Haniel A. Araujo, Minh Truong Do, Yu Qian +127 more
2025Nature4 citations Open access
Semantic Scholar
Oncogenic protein condensates modulate cell signal perception and drug tolerance
D. González-Martínez, L. Roth, T. Mumford, Asmin Tulpule +2 more
2022bioRxiv4 citations Open access
Semantic Scholar
Predicting patient treatment response and resistance via single-cell transcriptomics of their tumors
Sanju Sinha, R. Vegesna, S. Dhruba, Wei Wu +10 more
2022bioRxiv4 citations Open access
Semantic Scholar
CDK4 or CDK6 upregulation induces DNA replication stress and genomic instability to cause EGFR targeted therapy resistance in lung cancer
Beatrice Gini, Philippe Gui, Wei Wu, D. Kerr +11 more
2025bioRxiv3 citations Open access
Semantic Scholar
In vivo manipulation of the protein homeostasis network in rhabdomyosarcoma
Kristen Kwong, Yue Pan, Jacqueline Morales, Matthew Watson +7 more
2025OncoTarget3 citations Open access
Semantic Scholar
Drug Resistant Cancer Cells Show Increased Nuclear Mechanotransduction and Mechanically Targetable YAP-regulated Vulnerability
Miao Huang, Yinong Chen, Chenyu Liang, O. Narayan +30 more
2025Biomaterials3 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

D. Kerr×13
Invite
D. Kerr — researcher profile on SciRah
C. Blakely×11
Invite
C. Blakely — researcher profile on SciRah
J. Riess×9
Invite
J. Riess — researcher profile on SciRah
J. Rotow×8
Invite
J. Rotow — researcher profile on SciRah

Collin M. Blakely

×7

Invite

Collin M. Blakely — researcher profile on SciRah

Franziska Haderk×7

Invite

Franziska Haderk — researcher profile on SciRah

Yu-Ting Chou×6

Invite

Yu-Ting Chou — researcher profile on SciRah

Invite

Wei Wu — researcher profile on SciRah

T. Chakrabarti×6

Invite

T. Chakrabarti — researcher profile on SciRah

Shigeki Nanjo×5

Invite

Shigeki Nanjo — researcher profile on SciRah

Philippe Gui×5

Invite

Philippe Gui — researcher profile on SciRah

Invite

V. Olivas — researcher profile on SciRah